Patents by Inventor Ida Molgaard Knudsen

Ida Molgaard Knudsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8530192
    Abstract: The invention concerns a method for large-scale production of a polypeptide in eukaryote cells contained in a serum-free culture liquid, said method comprising (i) a propagation phase for said cells, where the cells are propagated in a first cell culture liquid, and (ii) a production phase for said cells, where the cells are present in a second cell culture medium liquid, wherein each of the cell culture liquids comprise a plant protein hydrolysate, and wherein the ratio between the concentration of the plant protein hydrolysate (C1) in the first cell culture liquid and the concentration of the plant protein hydrolysate (C2) in the second cell culture liquid is at least 1.5:1 (C1:C2).
    Type: Grant
    Filed: February 6, 2006
    Date of Patent: September 10, 2013
    Assignee: Novo Nordisk Healthcare AG
    Inventor: Ida Molgaard Knudsen
  • Patent number: 7947471
    Abstract: The invention provides a method for production of polypeptides in eukaryote microcarrier cell culture, the method comprising the steps of (i) Culturing cells expressing said polypeptide on microcarriers under conditions and at a setpoint temperature appropriate for expression of said polypeptide; (ii) Cooling the culture to a predetermined temperature below said setpoint; (iii) Sedimenting the microcarriers; and (iv) Harvesting all or part of the culture medium.
    Type: Grant
    Filed: September 7, 2007
    Date of Patent: May 24, 2011
    Assignee: Novo Nordisk Health Care A/G
    Inventor: Ida Mølgaard Knudsen
  • Publication number: 20090263866
    Abstract: The invention provides a method for industrial-scale production of FVII polypeptides in mammalian cell culture free of animal-derived components.
    Type: Application
    Filed: July 1, 2009
    Publication date: October 22, 2009
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: GILES WILSON, Ida Molgaard Knudsen
  • Patent number: 7521210
    Abstract: The invention provides a method for large-scale production of a polypeptide, such as a Factor VII or Factor VIIa polypeptide, in eukaryote cells, such as mammalian cells, contained in a culture liquid, said method comprising: monitoring the concentration of dissolved CO2 in the culture liquid, and constantly or intermittently sparging atmospheric air through the culture liquid, wherein the sparging rate of the air is controlled in relation to the monitored concentration of dissolved CO2 in the culture liquid. The method reduces or eliminates the use of bases while providing an excellent pH control. The invention also provides a culture vessel suitable for the methods.
    Type: Grant
    Filed: March 30, 2006
    Date of Patent: April 21, 2009
    Assignee: Novo Nordisk Healthcare A/G
    Inventor: Ida Mølgaard Knudsen
  • Publication number: 20090075331
    Abstract: The invention relates to methods for cultivating mammalian cells and for producing recombinant proteins in large-scale cultures of such cells. The proteins are, e.g., Factor VII or Factor VII-related polypeptides.
    Type: Application
    Filed: March 2, 2007
    Publication date: March 19, 2009
    Applicant: Novo Nordisk HealthCare A/G
    Inventor: Ida Molgaard Knudsen
  • Publication number: 20080254514
    Abstract: The invention concerns a method for large-scale production of a polypeptide in eukaryote cells contained in a serum-free culture liquid, said method comprising (i) a propagation phase for said cells, where the cells are propagated in a first cell culture liquid, and (ii) a production phase for said cells, where the cells are present in a second cell culture medium liquid, wherein each of the cell culture liquids comprise a plant protein hydrolysate, and wherein the ratio between the concentration of the plant protein hydrolysate (C1) in the first cell culture liquid and the concentration of the plant protein hydrolysate (C2) in the second cell culture liquid is at least 1.5:1 (C1:C2).
    Type: Application
    Filed: February 6, 2006
    Publication date: October 16, 2008
    Applicant: Novo Nordisk Health Care AG
    Inventor: Ida Molgaard Knudsen
  • Publication number: 20040185534
    Abstract: The invention relates to methods for cultivating mammalian cells and for producing recombinant proteins in large-scale cultures of such cells. The proteins are, e.g., Factor VII or Factor VII-related polypeptides.
    Type: Application
    Filed: March 21, 2003
    Publication date: September 23, 2004
    Inventor: Ida Molgaard Knudsen
  • Publication number: 20040185535
    Abstract: The invention provides a method for industrial-scale production of FVII polypeptides in mammalian cell culture free of animal-derived components.
    Type: Application
    Filed: March 21, 2003
    Publication date: September 23, 2004
    Inventors: Giles Wilson, Ida Molgaard Knudsen
  • Publication number: 20030096366
    Abstract: The invention provides a method for production of polypeptides in eukaryote microcarrier cell culture, the method comprising the steps of (i) Culturing cells expressing said polypeptide on microcarriers under conditions and at a setpoint temperature appropriate for expression of said polypeptide; (ii) Cooling the culture to a predetermined temperature below said setpoint; (iii) Sedimenting the microcarriers; and (iv) Harvesting all or part of the culture medium.
    Type: Application
    Filed: September 25, 2002
    Publication date: May 22, 2003
    Inventor: Ida Molgaard Knudsen